FUJIFILM Cellular Dynamics, Inc. develops and manufactures human cells worldwide. Its products include human cells in multiple cell types, human induced pluripotent stem cells, and custom iPSCs and iCell products; iCell Cardiomyocytes, which are purified human heart cells; and iCell Neurons that are purified human neurons typical of the forebrain for pre-clinical drug discovery and neurotoxicity testing, as well as disease modeling for Alzheimer’s diseases, Parkinson’s diseases, Huntington’s diseases, and others. It also offers iCell DopaNeurons that are purified human midbrain dopaminergic neurons; iCell Endothelial cells, which are interior surface blood vessel cells for use in vascular biology research, such as angiogenesis, atherosclerosis, inflammation, and other life science research; and iCell Hepatocytes that are human liver cells. In addition, the company offers MyCell products for making iPSCs for stem cell banking, cell modeling of specific ethnic or disease populations, and genetic engineering for in vitro research; and media and reprogramming kits for making iPSCs for limited research use. Furthermore, it offers neural cells, which includes iCell Astrocytes; iCell GABANeurons; iCell GlutaNeurons; iCell Microglia; iCell Motor Neurons; iCell Retinal Pigment Epithelial Cells; and hematopoietic and other cells, such as iCell iCell Macrophages; and iCell Mesenchymal Stem Cells. It serves biopharmaceutical companies, government research institutions, academic and nonprofit research institutions, contract research organizations, and stem cell banks. FUJIFILM Cellular Dynamics, Inc. was formerly known as Cellular Dynamics International, Inc. and changed its name to FUJIFILM Cellular Dynamics, Inc. in January 2018. The company was founded in 2004 and is based in Madison, Wisconsin. FUJIFILM Cellular Dynamics, Inc. operates as a subsidiary of FUJIFILM Holdings America Corporation.